Baseline characteristics of patients after matching according to type of heart failure.

<p>*/**Statistical significance of differences between groups tested by the ML chi-square test for categorical variables and by the independent Student’s <i>t</i>-test for continuous variables</p><p>*/**p<0.05/p<0.001</p><p>^aParameters used in a logistic regression model of a propensity score</p><p>^bMedication at discharge was computed on patients who were alive after discharge</p><p>LVEF—left ventricular ejection fraction, BP—blood pressure, MI—myocardial infarction, TIA—transient ischemic attack, PCI—percutaneous coronary intervention, CABG—coronary artery bypass graft, PM—pacemaker, ICD—implantable cardioverter–defibrillator, CRT—cardiac resynchronization therapy, COPD—chronic obstructive pulmonary disease, ARB—angiotensin-2 receptor blockers.</p><p>Baseline characteristics of patients after matching according to type of heart failure.</p

Baseline characteristics of patients before and after matching.

<p>*/**Statistical significance of differences between groups was tested by the ML chi-square test for categorical variables and by the independent Student’s <i>t</i>-test for continuous variables</p><p>*/**p<0.05/p<0.001</p><p>^aParameter used in a logistic regression model of a propensity score</p><p>^bParameter was not known for all patients, and statistics were computed on a reduced basis</p><p>^cMedication at discharge was computed on patients who were alive after discharge</p><p>LVEF—left ventricular ejection fraction, BP—blood pressure, MI—myocardial infarction, TIA—transient ischemic attack, PCI—percutaneous coronary intervention, CABG—coronary artery bypass graft, PM—pacemaker, ICD—implantable cardioverter–defibrillator, CRT—cardiac resynchronization therapy, COPD—chronic obstructive pulmonary disease, ARB—angiotensin-2 receptor blockers.</p><p>Baseline characteristics of patients before and after matching.</p

Long-term mortality for all patients according to a BMI of 25 kg/m² in a non-balanced and balanced dataset and for ADHF and <i>de novo</i> AHF patients.

<p>Long-term mortality for all patients according to a BMI of 25 kg/m² in a non-balanced and balanced dataset and for ADHF and <i>de novo</i> AHF patients.</p

Definition of datasets.

<p>Definition of datasets.</p

Thirty-day mortality according to the BMI category and type of heart failure.

<p>Thirty-day mortality according to the BMI category and type of heart failure.</p